Skip to main content
. 2004 Apr 3;328(7443):791. doi: 10.1136/bmj.38049.490255.DE

Table 3.

Antimicrobial resistance of isolates of Streptococcus pneumoniae and Haemophilus influenzae from children with non-severe pneumonia randomised to 3 days or 5 days of treatment with amoxicillin. Isolates cultured from nasopharyngeal swabs taken at enrolment (day 0) and final follow up (day 14)

No of resistant isolates/total tested (%)
P value of difference between treatments
Day 0
Day 14
Change from day 0 to day 14
Antibiotic resistance* 3 day treatment 5 day treatment 3 day treatment 5 day treatment At day 14
S pneumoniae:
Co-trimoxazole 253/380 (66.6) 252/381 (66.1) 106/159 (66.7) 111/142 (78.2) 0.02 0.05
Chloramphenicol 21/418 (5.0) 14/419 (3.3) 9/163 (5.5) 6/142 (4.2) 0.6 0.89
Oxacillin 67/408 (16.4) 64/413 (15.5) 17/160 (10.6) 17/141 (12.1) 0.7 0.59
Erythromycin 15/421 (3.6) 9/418 (2.2) 2/161 (1.2) 4/142 (2.8) 0.3 0.14
H influenzae:
Co-trimoxazole 118/217 (54.4) 133/218 (61.0) 74/129 (57.4) 64/106 (60.4) 0.64 0.65
Chloramphenicol 58/232 (25.0) 57/234 (24.4) 27/126 (21.4) 24/108 (22.2) 0.88 0.83
Erythromycin 69/230 (30.0) 65/232 (28.0) 39/126 (31.0) 31/108 (28.7) 0.7 0.97
Ampicillin 46/235 (19.6) 40/237 (16.9) 30/129 (23.3) 24/108 (22.2) 0.85 0.8
*

Resistance based on zone of inhibition in mm. S pneumoniae resistant to oxacillin (<20), chloramphenicol (≤20), erythromycin (≤15), co-trimoxazole (≤15). H influenzae resistant to ampicillin (<18), chloramphenicol (<25), erythromycin (<15), co-trimoxazole (<10).

HHS Vulnerability Disclosure